Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection

Citation
A. Chiappa et al., Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection, HEP-GASTRO, 48(37), 2001, pp. 229-234
Citations number
42
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
HEPATO-GASTROENTEROLOGY
ISSN journal
01726390 → ACNP
Volume
48
Issue
37
Year of publication
2001
Pages
229 - 234
Database
ISI
SICI code
0172-6390(200101/02)48:37<229:PVOTMT>2.0.ZU;2-0
Abstract
Background/Aims: Few studies have assessed the significance of prognostic f actors in cirrhotic patients undergoing resection for hepatocellular carcin oma. Methodology: Overall survival and disease-free survival were evaluated in 5 3 cirrhotic patients undergoing hepatic resection for supervening hepatocel lular carcinoma. The value of the UICC TNM classification, and the Izumi mo dified staging system on prognosis were analyzed. Results: In multivariate analysis lack of micro/macrovascular invasion were predictive for longterm outcome. The difference between stages 1 and 2 or stage 3 and 4A using the UICC TNM classification was not significant; with respect to survival or disease-free survival. UICC TNM classification was m odified as follows; stage 1, solitary tumor without vascular invasion; stag e 2, solitary or multiple tumor(s) involving adjacent vessel branch; stage 3, tumor(s) involving major vessel branch or with regional lymph node metas tases; stage 4, tumor(s) with distant metastases. TNM (modified in accordan ce with Izumi) showed a significant difference between each stage with resp ect to survival and disease-free survival. Conclusions: A uniform tumor classification of hepatocellular carcinoma is advocated. Our results show that the UICC TNM classification for hepatocell ular carcinoma is inadequate and may even on occasion lead to unnecessary r esection. The modified staging system of Izumi is superior in determining o utcome for cirrhotic patients with supervening hepatocellular carcinoma und ergoing resection.